Medindia LOGIN REGISTER
Medindia

Food and Herbs Interaction with Larotrectinib


Are you taking Larotrectinib? Are you aware of the dangers of combining Larotrectinib with certain foods and herbs? Drug-food-interactions are seldom discussed but can lead to undesirable side effects and potentially diminish the efficacy of the medication.

Larotrectinib Interactions with Food and Herbs

Grapefruit: Intake of grapefruit juice inhibits CYP3A metabolism that can increase the serum concentration of larotrectinib and cause some side effects including nausea, vomiting, dizziness, cough, and constipation (1 Trusted Source
FDA Approved Drug Products: Vitrakvi Larotrectinib Oral Capsules.

Go to source
).

St.John's Wort:This herb stimulates CYP3A metabolism and reduces the serum level of larotrectinib (2 Trusted Source
DrugBank Online. Larotrectinib: Uses, Interactions, Mechanism of Action.

Go to source
).

When and How to Take Larotrectinib

  • Larotrectinib is available only on prescription. It comes in the form of capsule and solution (liquid) to take orally (by mouth).
  • You will be usually advised to take it twice a day with or without food. Swallow the capsule as a whole instead of crushing, chewing or breaking it.
  • Take the medication around the same time every day for better results.
  • Follow the instructions as given by your doctor's prescription. Do not stop the use of larotrectinib without consulting your doctor even if you feel good (3 Trusted Source
    National Library of Medicine: Larotrectinib MedlinePlus Drug Information.

    Go to source
    ).

References

1. FDA Approved Drug Products: Vitrakvi Larotrectinib Oral Capsules. Retrieved on 8th June 2022 from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210861s000lbl.pdf
2. DrugBank Online. Larotrectinib: Uses, Interactions, Mechanism of Action. Retrieved on 9th June 2022 from: https://go.drugbank.com/drugs/DB14723
3. National Library of Medicine: Larotrectinib MedlinePlus Drug Information. Retrieved on 9th June 2022 from: https://medlineplus.gov/druginfo/meds/a619006.html

Drug Name : Larotrectinib

Larotrectinib is an anticancer agent that is indicated for the treatment of solid tumors in adults and children. It is specifically used in patients having gene modifications like NTRK gene fusion.
We recommend consulting your doctor to verify the information presented on this page or if you need any further clarifications.


Advertisement